Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A1 | Q14973 | 19/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21889743 | 0.92 | SLC10A1 (0.41) | SLC10A1 | |
| SCHEMBL21889667 | 0.88 | SLC10A1 (0.44) | SLC10A1 | |
| SCHEMBL21889632 | 0.88 | SLC10A1 (0.38) | SLC10A1 | |
| SCHEMBL21889644 | 0.87 | SLC10A1 (0.43) | SLC10A1 | |
| SCHEMBL21889670 | 0.84 | SLC10A1 (0.37) | SLC10A1 | |
| SCHEMBL21889633 | 0.84 | — | — | |
| SCHEMBL21889629 | 0.82 | SLC10A1 (0.41) | SLC10A1LMNAMAPT | |
| SCHEMBL21889672 | 0.82 | SLC10A1 (0.41) | SLC10A1 | |
| SCHEMBL21889642 | 0.79 | TSHR (0.40) | SLC10A1LMNAMAPT | |
| SCHEMBL21889630 | 0.79 | SLC10A1 (0.41) | SLC10A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230056135-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | EMORY UNIVERSITY (US) | 2023-02-23 | — | — | US | disclosed |
| WO-2020072955-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | EMORY UNIVERSITY (US) | 2020-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230056135-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | HAVCR2, HMBS, HDGF | SLC10A1 8/4885LMNA 828/4885MAPT 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.